Overview
Oxymatrine is under investigation in clinical trial NCT02202473 (Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects).
Background
Oxymatrine is under investigation in clinical trial NCT02202473 (Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects).
Indication
用于治疗慢性乙型病毒性肝炎。也可用于肿瘤放疗、化疗引起的白细胞低下及其他原因引起的白细胞减少症。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Marine Capsules | 国药准字H20010763 | 化学药品 | 胶囊剂 | 8/13/2020 | |
| Marine for Injection | 国药准字H20080585 | 化学药品 | 注射剂 | 9/4/2020 | |
| Marine for Injection | 国药准字H20030956 | 化学药品 | 注射剂(冻干粉针剂) | 12/24/2020 | |
| Marine for Injection | 国药准字H20041843 | 化学药品 | 注射剂 | 10/27/2020 | |
| Marine for Injection | 国药准字H20040190 | 化学药品 | 注射剂(冻干粉针剂) | 12/11/2020 | |
| Marine for Injection | 国药准字H20050927 | 化学药品 | 注射剂 | 8/4/2020 | |
| Marine for Injection | 国药准字H20050101 | 化学药品 | 注射剂 | 10/15/2020 | |
| Marine for Injection | 国药准字H20055103 | 化学药品 | 注射剂 | 7/23/2020 | |
| Marine for Injection | 国药准字H20030784 | 化学药品 | 注射剂 | 11/8/2023 | |
| Marine for Injection | 国药准字H20031153 | 化学药品 | 注射剂 | 10/21/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||